Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) dose that’s inconsistent with US Food and Drug Administration labeling—a practice believed, in many cases, to be ...
The prevalence of inappropriate direct oral anticoagulant (DOAC) dosing in patients with atrial fibrillation (AF) was 25%. Several demographic factors such as advanced age, presence of chronic kidney ...
Among patients hospitalized for atrial fibrillation (AF) or flutter, prescription of an off-label dose of a direct oral anticoagulant (DOAC) at discharge remains relatively common, according to data ...
Adoption of DOAC population management tool dashboard before July 2018 linked to decline in off-label dosing prescriptions HealthDay News — Early adoption of the direct oral anticoagulant (DOAC) ...
The risk for death goes up for patients with atrial fibrillation (AF) who are put on direct oral anticoagulants (DOAC) at dosages other than those approved for stroke prevention, whether higher or ...
A first-of-its-kind exploratory study finds that over half of frail, older patients admitted to the hospital for acute illness and are on blood thinners from the direct oral anticoagulant (DOAC) class ...
The use of a population health management tool may reduce adverse events that may arise from the inappropriate prescribing of direct-acting oral anticoagulants (DOACs). The inappropriate use of direct ...
MONDAY, Aug. 5, 2024 (HealthDay News) -- Direct oral anticoagulant (DOAC) prescribing oversight for off-label prescribing is beneficial while patients are prescribed DOAC, according to a study ...
WEDNESDAY, Sept. 25, 2024 (HealthDay News) -- Early adoption of the direct oral anticoagulant (DOAC) population management dashboard, the purpose of which includes pharmacist review and correction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback